You are using an older browser version. Please use a supported version for the best MSN experience.

ABBVIE INC.

NYSE: ABBV
82.89
-1.36
-1.61%
  • Key statistics
  • Growth
  • Profitability
  • Price ratios
Industry Pharmaceuticals
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 33.27B

    • Net Income

    • 7.84B

    • Market Cap.

    • 146.29B

    • Enterprise Value

    • 230.10B

    • Net Profit Margin %

    • 23.69

    • PEG (Price/Earnings Growth) Ratio

    • 0.43

    • Beta

    • 0.68

    • Forward P/E

    • 8.07

    • Price/Sales

    • 0.00

    • Price/Book Value

    • -

    • Price/Cash flow

    • 15.02

      • EBITDA

      • 15.56B

      • Return on Capital %

      • 6.73

      • Return on Equity %

      • 224.88

      • Return on Assets %

      • 6.73

      • Book Value/Share

      • 8.34

      • Shares Outstanding

      • 1.76B

      • Last Split Factor (Date)

      • 1:0 (-)

      • Last Dividend (Ex-Date)

      • 1.18 (4/14/2020)

      • Dividend Declaration Date

      • 2/20/2020

      Analyst Recommendation
      10/21/2020
      Buy
        • 1 Year Price Target

        • 110.00

        • Analysts

        • 23

        • EPS Estimate

        • 10.43

        • Cashflow Estimate

        • -

        Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

        • Sales (Revenue)

          Q/Q (Last Year)

        • 26.29

        • 7.39

        • Net Income

          YTD/YTD (Last Year)

        • 36.55

        • -2.54

        • Net Income

          Q/Q (Last Year)

        • -203.14

        • 6.66

        • Sales (Revenue)

          5-Year Annual Average

        • 10.76

        • -

        • Net Income

          5-Year Annual Average

        • 34.62

        • -

        • Dividends

          5-Year Annual Average

        • 20.86

        • -

        • Profit Margins (%)

        • Company

        • Industry

        • Gross Margin

        • 77.14

        • 63.01

        • Pre-Tax Margin

        • 25.33

        • 15.47

        • Net Profit Margin

        • 23.69

        • 12.77

        • Average Gross Margin

          5-Year Annual Average

        • 77.14

        • 63.14

        • Average Pre-Tax Margin

          5-Year Annual Average

        • 25.14

        • 15.98

        • Average Net Profit Margin

          5-Year Annual Average

        • 21.34

        • 13.04

        • Price Ratios

        • Company

        • Industry

        • Current P/E Ratio

        • 18.23

        • 18.23

        • P/E Ratio 5-Year High

        • 27.28

        • -

        • P/E Ratio 5-Year Low

        • 16.76

        • -

        • Price/Sales Ratio

        • 4.47

        • 3.89

        • Price/Book Value

        • -

        • 4.13

        • Price/Cash Flow Ratio

        • 15.02

        • 15.43

        Current Historical
        • Financial health
        • Trading statistics
        • Management effectiveness
        Industry Pharmaceuticals
        • Financial Ratios

        • Company

        • Industry

        • Debt/Equity Ratio

        • 5.58

        • 0.75

        • Current Ratio

        • 0.86

        • 1.49

        • Quick Ratio

        • 3.06

        • 1.15

        • Leverage Ratio

        • 10.17

        • 2.51

        • Book Value/Share

        • 8.34

        • 2.10

        • Key Metrics

        • Company

          • Shares Short

            as of -

          • -

          • Short Ratio

            as of -

          • -

          • Short % of Float

            as of -

          • -

          • Shares Short

            prior month

          • -

          • Trailing Annual Dividend Yield

          • -

          • 5 Year Average Dividend Yield

          • 368.90

          • Key Metrics

          • Company

            • Payout Ratio

            • 104.42

            • Dividend Date

            • 2/20/2020

            • Ex-Dividend Date

            • 4/14/2020

            • Last Split Factor

              new per old

            • 1:0

            • Last Split Date

            • -

            • Key Metrics

            • Company

            • Industry

            • Return on Equity %

              (5-Year Average)

            • 224.88

              (1,503.97)

            • 14.30

              (13.92)

            • Return on Assets %

              (5-Year Average)

            • 6.73

              (9.90)

            • 7.09

              (6.12)

            • Return on Capital %

              (5-Year Average)

            • 8.43

              (12.72)

            • 7.80

              (8.00)

            • Income/Employee

            • 262.73k

            • 28.61k

            • Inventory Turnover

            • 4.45

            • 2.21

            • Asset Turnover

            • 0.45

            • 0.46

            Current Historical
            AdChoices
            AdChoices
            AdChoices
            image beaconimage beaconimage beacon